BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/2/2015 11:48:00 AM | Browse: 1282 | Download: 1992
Publication Name World Journal of Stem Cells
Manuscript ID 13889
Country France
ISSN 1948-0210 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Hematology
Manuscript Type Review
Article Title Adoptive immunotherapy for acute leukemia: New insights in chimeric antigen receptors
Manuscript Source Invited Manuscript
All Author List Maël Heiblig, Mohamed Elhamri, Mauricette Michallet and Xavier Thomas
Funding Agency and Grant Number
Corresponding Author Xavier Thomas, MD, PhD, Hematology Department, Lyon-Sud Hospital, 165 chemin du Grand Revoyet, 69495 Pierre Bénite cedex, France. xavier.thomas@chu-lyon.fr
Key Words Chimeric antigen receptors; Adoptive immu­no­therapy; Acute leukemia; T cells; Immune surveil­lance
Core Tip Leukemia cells ultimately escape to the immune system, due to various mechanisms such as limited availability of tumor specific T cells or down-regulation in major histocompatibility complex expression. Chimeric antigen receptor (CAR) T cell technology redirects immune reactivity towards a broad variety of chosen antigens in a human leukocyte antigen-independent manner. Recent introduction of co-stimulatory domains in the CAR construct enhances significantly in vitro and in vivo expansion and persistence of these genetically modified T cells. First clinical trials, especially with anti-CD19 CAR T cells, report promising results in acute lymphoblastic leukemia.
Publish Date 2015-08-27 10:51
Citation Heiblig M, Elhamri M, Mauricette M, Thomas X. Adoptive immunotherapy for acute leukemia: New insights in chimeric antigen receptors. World J Stem Cells 2015; 7(7): 1022-1038
URL http://www.wjgnet.com/1948-0210/full/v7/i7/1022.htm
DOI http://dx.doi.org/10.4252/wjsc.v7.i7.1022
Full Article (PDF) WJSC-7-1022.pdf
Full Article (Word) WJSC-7-1022.doc